Heart failure & cardiomyopathies

Disparities in prescriptions among Danish heart failure patients: a national longitudinal cohort study

HeartPublished Retrospective cohort study

Authors' conclusion

Substantial disparity was found in prescriptions for the potentially life-saving medications, with lack of prescriptions being associated with lower education, lower income and several demographic characteristics.

Study context

Population
Danish HF patients diagnosed on or after the updated ESC guidelines, universal healthcare system
Participants
43,625 vs 2,819
Exposure
Demographic, geographic and socioeconomic factors and prescription of angiotensin receptor-neprilysin inhibitors (ARNi) and SGLT2i
  • ARNin = 43,625
  • SGLT2in = 2,819
Outcome
Redemption of a prescription for ARNi or SGLT2i
Methodological detailsnational registers, longitudinal, Follow-up until prescription redemption, emigration, death or censoring on 30 June 2022; Aalen-Johansen estimator and Cox models
  • National registers
  • Longitudinal
  • Follow-up until prescription redemption, emigration, death or censoring on 30 June 2022; Aalen-Johansen estimator and Cox models

Main finding

As reported in the abstract

Factors associated with lack of prescriptions (women, older age, living alone, non-native Danish or descendant)
Hazard ratio (95% CI)
ARNilowest HR of the range
0.31(0.28–0.36)
ARNihighest HR of the range
0.86(0.80–0.93)
SGLT2ilowest HR of the range
0.49(0.41–0.58)
SGLT2ihighest HR of the range
0.93(0.72–1.20)

Observational data: associations, not effects.

Further findings

Social gradient in prescriptions

Social gradient for both ARNi and SGLT2i; statistically significant for ARNi

Original publication

Disparities in prescriptions among Danish heart failure patients: a national longitudinal cohort study. Heart. Published 10 May 2025. doi:10.1136/heartjnl-2024-325562

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.